On February 21, 2023 Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, reported that Dr. Ulrich Dauer, CEO of Vivoryon Therapeutics, will present at the following investor conferences and industry events (Press release, Vivoryon Therapeutics, FEB 21, 2023, View Source [SID1234627456]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BioCapital Europe 2023

Date: March 9, 2023

Time: 09:40 am CET

Venue: Hotel Sofitel Legend The Grand Amsterdam; Amsterdam, The Netherlands

Barclays Global Healthcare Conference

Date: March 16, 2023

Time: 08:00 am EDT / 01:00 pm CET

Venue: Loews Miami Beach Hotel; Miami, USA

A webcast of the presentation will be available via the "Presentations & Webcasts" page in the Investor Relations section on the Company’s website at www.vivoryon.com and will be archived on the Company’s website for 30 days following the conference.

German Biotechnology Days (Deutsche Biotechnologietage) 2023

Date: March 29, 2023

Time: 02:00 pm CEST

Venue: RheinMain CongressCenter; Wiesbaden, Germany